Redmile Group Leads Series C Round in Evox Therapeutics
Posted on 02/21/2021
Evox Therapeutics is a U.K. exosome therapeutics startup. Evox Therapeutics raised £69.2 million in Series C funding. Redmile Group led, and was joined by OrbiMed, Invus and insiders Oxford Sciences Innovation, GV (Google Ventures), Eli Lilly, and Cowen Healthcare Investments. The Oxford-based company’s internal pipeline includes preclinical drug candidates designed to carry proteins and nucleic […]
